Funding excellent research
Aiming for a life without EB
EB Resnet supports and coordinates research funding on behalf of its member patient organisations and partners. We currently offer three funding schemes: Research grants through scheduled Calls for proposals, Ad-hoc grants our flexible funding scheme, and Co-funding for industry-partnering projects.
EB Resnet welcomes proposals for innovative research and clinical development of treatments or diagnostics. All proposals are evaluated for scientific excellence, feasibility and value for money, and whether they address the priority needs of people with EB. We undertake peer review to ensure that only the best research is funded.
Our funding schemes. How do your ideas fit in?
closed since 06 September 2022
| || || |
Closed Calls 2022
This year's All Priorities Call closed on 06 September 2022. Full details including deadlines and scope are displayed under Closed Call 'AP Call 2022'.
In addition, a Special Ad-hoc Call 2022 focussing on Proof-of-Concept Proposals on Drug Repurposing for EB closed on 06 September 2022 too. Full details including deadlines and scope are displayed under Closed Call 'Special Ad-hoc Call 2022'.
The results of the All Priorities Call 2021 can be found in the overview table for 2021.